ROYCE & ASSOCIATES LP - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 282 filers reported holding BLUEBIRD BIO INC in Q3 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2020$324,000
-78.8%
6,000
-76.0%
0.00%
-82.4%
Q2 2020$1,526,000
+74.8%
25,000
+31.6%
0.02%
+41.7%
Q1 2020$873,000
-47.6%
19,0000.0%0.01%
-20.0%
Q4 2019$1,667,000
+14.2%
19,000
+90.0%
0.02%
+50.0%
Q3 2018$1,460,000
-7.0%
10,0000.0%0.01%
-9.1%
Q2 2018$1,570,00010,0000.01%
Other shareholders
BLUEBIRD BIO INC shareholders Q3 2020
NameSharesValueWeighting ↓
Monashee Investment Management LLC 125,000$13,131,0005.55%
Cormorant Asset Management, LP 275,000$28,889,0004.79%
Eventide Asset Management 569,700$59,847,0003.73%
Crosspoint Capital Strategies, LLC 28,937$3,040,0002.66%
Casdin Capital, LLC 65,000$6,828,0002.53%
ARK Investment Management 119,683$12,573,0002.45%
RTW INVESTMENTS, LP 104,383$10,965,0002.31%
Taylor Wealth Management Partners 38,368$4,031,0001.82%
First Light Asset Management, LLC 33,780$3,549,0001.19%
Atika Capital Management LLC 25,000$2,627,0000.92%
View complete list of BLUEBIRD BIO INC shareholders